These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36170933)

  • 1. Pharmacist-Initiated De-Prescribing Efforts Reduce Inappropriate Continuation of Acid-Suppression Therapy Initiated in the ICU.
    Cascone AE; Sullivan J; Ackerbauer K; Patel S; Lindale DK; Tatro H; Feeney ME
    Am J Med; 2023 Feb; 136(2):186-192. PubMed ID: 36170933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
    Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
    Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pharmacy-Based Electronic Handoff Tool to Reduce Discharge Prescribing of Atypical Antipsychotics Initiated in the Intensive Care Unit: A Quality Improvement Initiative.
    Kram BL; Schultheis JM; Kram SJ; Cox CE
    J Pharm Pract; 2019 Aug; 32(4):434-441. PubMed ID: 29486664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.
    Masood U; Sharma A; Bhatti Z; Carroll J; Bhardwaj A; Sivalingam D; Dhamoon AS
    Inquiry; 2018; 55():46958018759116. PubMed ID: 29502481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pharmacy resident led education on resident physician prescribing habits associated with stress ulcer prophylaxis in non-intensive care unit patients.
    Agee C; Coulter L; Hudson J
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S48-52. PubMed ID: 25991596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of A Collaborative Strategy to Reduce the Inappropriate Use of Acid Suppressive Therapy in Non-Intensive Care Unit Patients.
    Belfield KD; Kuyumjian AG; Teran R; Amadi M; Blatt M; Bicking K
    Ann Pharmacother; 2017 Jul; 51(7):577-583. PubMed ID: 28622739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of an electronic medical record-based alarm in the optimization of stress ulcer prophylaxis.
    Saad EJ; Bedini M; Becerra AF; Martini GD; Gonzalez JG; Bolomo A; Castellani L; Quiroga S; Morales C; Leathers J; Balderramo D; Albertini RA
    Gastroenterol Hepatol; 2018; 41(7):432-439. PubMed ID: 29895412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.
    Shin S
    Ther Clin Risk Manag; 2015; 11():649-57. PubMed ID: 26005351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate continuation of stress ulcer prophylactic therapy after discharge.
    Wohlt PD; Hansen LA; Fish JT
    Ann Pharmacother; 2007 Oct; 41(10):1611-6. PubMed ID: 17848420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Risk Factors for Inappropriate Continuation of Proton Pump Inhibitors After Discharge From the Intensive Care Unit.
    Blackett JW; Faye AS; Phipps M; Li J; Lebwohl B; Freedberg DE
    Mayo Clin Proc; 2021 Oct; 96(10):2550-2560. PubMed ID: 33308869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients.
    Choi YJ; Sim J; Jung YT; Shin S
    Br J Clin Pharmacol; 2020 May; 86(5):903-912. PubMed ID: 31840265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress ulcer prophylaxis: reducing non-indicated prescribing after hospital discharge.
    Hatch JB; Schulz L; Fish JT
    Ann Pharmacother; 2010 Oct; 44(10):1565-71. PubMed ID: 20841521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency.
    Mousavi M; Dashti-Khavidaki S; Khalili H; Farshchi A; Gatmiri M
    Int J Pharm Pract; 2013 Aug; 21(4):263-9. PubMed ID: 23418812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
    Redfern RE; Brown M; Karhoff KL; Middleton JL
    South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of stress ulcer prophylaxis prescription in the intensive care unit: an observational study.
    Franchitti M; Piubellini J; Sadeghipour F; Eckert P; Voirol P; Schneider AG
    Swiss Med Wkly; 2020 Aug; 150():w20322. PubMed ID: 32905610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and cost of stress ulcer prophylaxis after discharge from the intensive care unit: a retrospective study.
    Tan B; Norman R; Litton E; Heath C; Hawkins DJ; Krishnamurthy R; Sonawane R; Anstey MH
    Crit Care Resusc; 2016 Dec; 18(4):270-274. PubMed ID: 27903209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for the Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis and Peptic Ulcer Bleeding in Hospitalized Patients.
    Clarke K; Adler N; Agrawal D; Bhakta D; Sata SS; Singh S; Gupta A; Pahwa A; Pherson E; Sun A; Volpicelli F; Cho HJ
    Am J Med; 2022 Mar; 135(3):313-317. PubMed ID: 34655535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
    Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
    Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.